Suppression of proteoglycan-Induced autoimmune arthritis by myeloid-Derived suppressor cells generated in vitro from murine bone marrow

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Kurkó, Júlia ^a,b   Vida, András ^a   Ocskó, Tímea ^a   Tryniszewska, Beata ^a   Rauch, Tibor A ^a   Glant, Tibor T ^a   Szekanecz, Zoltán ^b   Mikecz, Katalin ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; NITRIC OXIDE; NOS2 PROTEIN, MOUSE; PROTEOGLYCAN;

ADOPTIVE TRANSFER; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ARTICLE; BONE MARROW CELL; COCULTURE; CONTROLLED STUDY; EXPERIMENTAL ARTHRITIS; FEMALE; LYMPHOCYTE PROLIFERATION; MOUSE; MYELOID DERIVED SUPPRESSOR CELL; NONHUMAN; PROTEOGLYCAN INDUCED ARTHRITIS; RHEUMATOID ARTHRITIS; SCID MOUSE; SUPPRESSOR CELL; SYNOVIAL FLUID; T LYMPHOCYTE; ANIMAL; ANTAGONISTS AND INHIBITORS; ANTIBODY SPECIFICITY; ARTHRITIS, RHEUMATOID; BAGG ALBINO MOUSE; BIOSYNTHESIS; CELL CULTURE; CELL PROLIFERATION; METABOLISM; PHYSIOLOGY; TRANSPLANTATION;

ADOPTIVE TRANSFER; ANIMALS; ARTHRITIS, RHEUMATOID; BONE MARROW CELLS; CELL PROLIFERATION; CELLS, CULTURED; FEMALE; MICE, INBRED BALB C; MICE, SCID; MYELOID CELLS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; ORGAN SPECIFICITY; PROTEOGLYCANS;

EID: 84930630721     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0111815     Document Type: Article

References (54)

1. Fox DA (2005) Etiology and Pathogenesis of Rheumatoid Arthritis. In: Koopman WJ, Moreland LW, editors. Arthritis and Allied Conditions: A Textbook of Rheumatology. Philadelphia: Lippincott Williams & Wilkins. 1085- 1102.
2. Firestein GS (2005) Rheumatoid arthritis: Etiology and pathogeneis of rheumatoid arthritis. In: Ruddy S, Harris ED, Sledge CB, Kelley WN, editors. Kelley's Textbook of Rheumatology. Philadelphia, PA: W.B.Saunders Co. 996- 1045.
3. Moore JJ, Snowden J, Pavletic S, Barr W, Burt R (2003) Hematopoietic stem cell transplantation for severe rheumatoid arthritis. Bone Marrow Transplant 32 Suppl1: S53-S56.
4. Brinkman DM, de Kleer IM, ten Cate R, van Rossum MA, Bekkering WP, et al. (2007) Autologous stem cell transplantation in children with severe progressive systemic or polyarticular juvenile idiopathic arthritis: long-term follow-up of a prospective clinical trial. Arthritis Rheum 56: 2410-2421.
5. Subiza JL, Vinuela JE, Rodriguez R, Gil J, Figueredo MA, et al. (1989) Development of splenic natural suppressor (NS) cells in Ehrlich tumor-bearing mice. Int J Cancer 44: 307-314.
6. Nagaraj S, Gabrilovich DI (2010) Myeloid-derived suppressor cells in human cancer. Cancer J 16: 348-353.
7. Serafini P, Borrello I, Bronte V (2006) Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression. Semin Cancer Biol 16: 53-65.
8. Gabrilovich DI, Nagaraj S (2009) Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 9: 162-174.
9. Pastula A, Marcinkiewicz J (2011) Myeloid-derived suppressor cells: A doubleedged sword? Int J Exp Pathol 92: 73-78.
10. Youn JI, Gabrilovich DI (2010) The biology of myeloid-derived suppressor cells: The blessing and the curse of morphological and functional heterogeneity. Eur J Immunol 40: 2969-2975.
11. Lowell CA, Berton G (1999) Integrin signal transduction in myeloid leukocytes. J Leukoc Biol 65: 313-320.
12. Ribechini E, Greifenberg V, Sandwick S, Lutz MB (2010) Subsets, expansion and activation of myeloid-derived suppressor cells. Med Microbiol Immunol 199: 273-281.
13. Youn JI, Nagaraj S, Collazo M, Gabrilovich DI (2008) Subsets of myeloidderived suppressor cells in tumor-bearing mice. J Immunol 181: 5791-5802.
14. Ioannou M, Alissafi T, Lazaridis I, Deraos G, Matsoukas J, et al. (2012) Crucial role of granulocytic myeloid-derived suppressor cells in the regulation of central nervous system autoimmune disease. J Immunol 188: 1136-1146.
15. Movahedi K, Guilliams M, Van den Bossche J, Van den Bergh R, Gysemans C, et al. (2008) Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. Blood 111: 4233- 4244.
16. Nagaraj S, Gupta K, Pisarev V, Kinarsky L, Sherman S, et al. (2007) Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer. Nat Med 13: 828-835.
17. Haile LA, von Wasielewski R, Gamrekelashvili J, Kruger C, Bachmann O, et al. (2008) Myeloid-derived suppressor cells in inflammatory bowel disease: A new immunoregulatory pathway. Gastroenterology 135: 871-81, 881.
18. Kerr EC, Raveney BJ, Copland DA, Dick AD, Nicholson LB (2008) Analysis of retinal cellular infiltrate in experimental autoimmune uveoretinitis reveals multiple regulatory cell populations. J Autoimmun 31: 354-361.
19. Yin B, Ma G, Yen CY, Zhou Z, Wang GX, et al. (2010) Myeloid-derived suppressor cells prevent type 1 diabetes in murine models. J Immunol 185: 5828-5834.
20. Fujii W, Ashihara E, Hirai H, Nagahara H, Kajitani N, et al. (2013) Myeloidderived suppressor cells play crucial roles in the regulation of mouse collageninduced arthritis. J Immunol 191: 1073-1081.
21. Egelston C, Kurko J, Besenyei T, Tryniszewska B, Rauch TA, et al. (2012) Suppression of dendritic cell maturation and T cell proliferation by synovial fluid myeloid cells from mice with autoimmune arthritis. Arthritis Rheum 64: 3179- 3188.
22. Glant TT, Mikecz K, Arzoumanian A, Poole AR (1987) Proteoglycan-induced arthritis in BALB/c mice. Clinical features and histopathology. Arthritis Rheum 30: 201-212.
23. Glant TT, Finnegan A, Mikecz K (2003) Proteoglycan-induced arthritis: immune regulation, cellular mechanisms and genetics. Crit Rev Immunol 23: 199-250.
24. Hutas G, Bajnok E, Gal I, Finnegan A, Glant TT, et al. (2008) CD44-specific antibody treatment and CD44 deficiency exert distinct effects on leukocyte recruitment in experimental arthritis. Blood 112: 4999-5006.
25. Ribechini E, Leenen PJ, Lutz MB (2009) Gr-1 antibody induces STAT signaling, macrophage marker expression and abrogation of myeloid-derived suppressor cell activity in BM cells. Eur J Immunol 39: 3538-3551.
26. Faust N, Varas F, Kelly LM, Heck S, Graf T (2000) Insertion of enhanced green fluorescent protein into the lysozyme gene creates mice with green fluorescent granulocytes and macrophages. Blood 96: 719-726.
27. Angyal A, Egelston C, Kobezda T, Olasz K, Laszlo A, et al. (2010) Development of proteoglycan-induced arthritis depends on T cell-supported autoantibody production, but does not involve significant influx of T cells into the joints. Arthritis Res Ther 12: R44.
28. Berlo SE, Guichelaar T, ten Brink CB, Van Kooten PJ, Hauet-Broere F, et al. (2006) Increased arthritis susceptibility in cartilage proteoglycan-specific T cell receptor-transgenic mice. Arthritis Rheum 54: 2423-2433.
29. Bosma MJ, Carroll AM (1991) The SCID mouse mutant: Definition, characterization, and potential uses. Annu Rev Immunol 9: 323-350.
30. Hanyecz A, Berlo SE, Szanto S, Broeren CPM, Mikecz K, et al. (2004) Achievement of a synergistic adjuvant effect on arthritis induction by activation of innate immunity and forcing the immune response toward the Th1 phenotype. Arthritis Rheum 50: 1665-1676.
31. Lutz MB, Kukutsch N, Ogilvie AL, Rossner S, Koch F, et al. (1999) An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods 223: 77-92.
32. Glant TT, Radacs M, Nagyeri G, Olasz K, Laszlo A, et al. (2011) Proteoglycaninduced arthritis and recombinant human proteoglycan aggrecan G1 domaininduced arthritis in BALB/c mice resembling two subtypes of rheumatoid arthritis. Arthritis Rheum 63: 1312-1321.
33. Bardos T, Mikecz K, Finnegan A, Zhang J, Glant TT (2002) T and B cell recovery in arthritis adoptively transferred to SCID mice: Antigen-specific activation is required for restoration of autopathogenic CD4+ Th1 cells in a syngeneic system. J Immunol 168: 6013-6021.
34. Dolcetti L, Peranzoni E, Ugel S, Marigo I, Fernandez GA, et al. (2010) Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF. Eur J Immunol 40: 22-35.
35. Lechner MG, Liebertz DJ, Epstein AL (2010) Characterization of cytokineinduced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells. J Immunol 185: 2273-2284.
36. Wright HL, Bucknall RC, Moots RJ, Edwards SW (2012) Analysis of SF and plasma cytokines provides insights into the mechanisms of inflammatory arthritis and may predict response to therapy. Rheumatology (Oxford) 51: 451-459.
37. Peranzoni E, Zilio S, Marigo I, Dolcetti L, Zanovello P, et al. (2010) Myeloidderived suppressor cell heterogeneity and subset definition. Curr Opin Immunol 22: 238-244.
38. Charles JF, Hsu LY, Niemi EC, Weiss A, Aliprantis AO, et al. (2012) Inflammatory arthritis increases mouse osteoclast precursors with myeloid suppressor function. J Clin Invest 122: 4592-4605.
39. Almand B, Clark JI, Nikitina E, van Beynen J, English NR, et al. (2001) Increased production of immature myeloid cells in cancer patients: A mechanism of immunosuppression in cancer. J Immunol 166: 678-689.
40. Rossner S, Voigtlander C, Wiethe C, Hanig J, Seifarth C, et al. (2005) Myeloid dendritic cell precursors generated from bone marrow suppress T cell responses via cell contact and nitric oxide production in vitro. Eur J Immunol 35: 3533- 3544.
41. Forghani P, Harris W, Giver CR, Mirshafiey A, Galipeau J, et al. (2013) Properties of immature myeloid progenitors with nitric-oxide-dependent immunosuppressive activity isolated from bone marrow of tumor-free mice. PLOS ONE 8: E64837.
42. Bingisser RM, Tilbrook PA, Holt PG, Kees UR (1998) Macrophage-derived nitric oxide regulates T cell activation via reversible disruption of the Jak3/STAT5 signaling pathway. J Immunol 160: 5729-5734.
43. Farrell AJ, Blake DR, Palmer RM, Moncada S (1992) Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann Rheum Dis 51: 1219-1222.
44. Bjelle A, Norberg B, Sjogren G (1982) The cytology of joint exudates in rheumatoid arthritis. Morphology and preparation techniques. Scand J Rheumatol 11: 124-128.
45. Yamamoto T, Nishiura H, Nishida H (1996) Molecular mechanisms to form leukocyte infiltration patterns distinct between synovial tissue and fluid of rheumatoid arthritis. Semin Thromb Hemost 22: 507-511.
46. Huang B, Pan PY, Li Q, Sato AI, Levy DE, et al. (2006) Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host. Cancer Res 66: 1123- 1131.
47. Highfill SL, Rodriguez PC, Zhou Q, Goetz CA, Koehn BH, et al. (2010) Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13. Blood 116: 5738-5747.
48. Roord ST, de Jager W, Boon L, Wulffraat N, Martens A, et al. (2008) Autologous bone marrow transplantation in autoimmune arthritis restores immune homeostasis through CD4+CD25+Foxp3+ regulatory T cells. Blood 111: 5233-5241.
49. Zhao E, Xu H, Wang L, Kryczek I, Wu K, et al. (2012) Bone marrow and the control of immunity. Cell Mol Immunol 9: 11-19.
50. Jiao Z, Hua S, Wang W, Wang H, Gao J, et al. (2013) Increased circulating myeloid-derived suppressor cells correlated negatively with Th17 cells in patients with rheumatoid arthritis. Scand J Rheumatol 42: 85-90.
51. Kurko J, Vida A, Glant TT, Scanzello CR, Katz RS, et al. (2014) Identification of myeloid-derived suppressor cells in the synovial fluid of patients with rheumatoid arthritis: A pilot study. BMC Musculoskelet Disord 15: 281.
52. Holmdahl R, Jonsson R, Larsson P, Klareskog L (1988) Early appearance of activated CD4+ T lymphocytes and class II antigen-expressing cells in joints of DBA/1 mice immunized with type II collagen. Lab Invest 58: 53-60.
53. Nguyen LT, Jacobs J, Mathis D, Benoist C (2007) Where FoxP3-dependent regulatory T cells impinge on the development of inflammatory arthritis. Arthritis Rheum 56: 509-520.
54. Cope AP (2002) Studies of T-cell activation in chronic inflammation. Arthritis Res 4 Suppl3: S197-S211.